A comparative study of the critical factors involved in the induction of tolerance to mouse tumors in rats treated after birth by intraperitoneal injections of mouse spleen, liver, and tumor cell suspensions has revealed that the induction and maintenance of tolerance is essentially conditioned by re peated inoculation of the antigen. Tolerance to mouse tumors was conferred on rats by spleen cells, provided the latter were administered in daily inoculations the first 10 days of life. The incidence rate of actively developing tumors and the duration of tolerance were directly related to the total dose of postna tally administered spleen cells. By the administration of a second course of large doses of spleen cells, tolerance could be maintained after the onset of recovery from paralysis. Similar ly, tolerance could be reinduced by repeated inoculations of tumor cells in rats that had been sensitized by a mouse skin heterograft during the period of recovery from paralysis. Ac tively growing tumors developed in rats treated with nonviable liver cells during the first week of life and thereafter repeated ly reinoculated with tumor cells. Tolerance was induced by repeated inoculations of tumor cells administered during the first 3 to 5 days of life; a similar dose proved inefficient when administered in a single inoculation during the neonatal pen od.
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The theoretical implications of these results are discussed.
INTRODUCTION
It was previously noticed by the authors (29â€"31) that the induction in mice of tolerance to some types of rat tumor was critically dependent on the repeated inoculation of tumor cells or a mixture of tumor and spleen cells during the first 3 days of life. The same total amount of cells administered in a single inoculation to newborn animals had no effect. Although the tumor resulting from the neonatal inoculations were rejected between the 10th and the 14th day of life, actively growing tumors appeared in mice reinoculated with tumor cells during this interval.
Rat spleen cells enhanced the tolerance-inducing effect of tumor cells when administered together with the latter, but were unable to induce tolerance when administered by them selves to newborn mice. This finding, as well as the very small number of rat metaphases detectable in the lymphoid tissues Received March 18, 1968 ; accepted August 27, 1968. of tolerant mice, may be accounted for by the reduced ability of spleen cells to multiply in a heterologous environment as against a homologous one (3, 14, 27) .
Since repeated administration of the antigen appears to be the critical factor involved in the induction of heterograft tol erance, the authors have postulated the existence in this in stance of a mechanism similar to that operating in immunolog ic paralysis induced by heterologous proteins (29, 30) . In the latter case â€oea long continued administration of antigen is often requiredâ€• (6) . In drawing this analogy one should, however, take into account that if a valid distinction is to be made between transplantation tolerance and immunologic paralysis, this distinction must be derived from the particular quantita tive characters pertaining to the induction and maintenance of immunologic unresponsiveness under circumstances in which the tolerance-inducing stimulus is or is not capable of â€oeself reproductionâ€• (13) . This is why the argument for the above stroyed. In the case of CBA skin xenografts on Lewis rats, the mean survival time was 6.40 Â±0.3 days (14 animals).
Antibody
Tests. Since specific immune tolerance is some times revealed as a failure to produce antibody (which is known to be involved in the rejection of heterografts), hemag glutinating and cytotoxic antibody titers were determined in the blood sera of grafted rats. Blood was collected by amputa tion of the tail on the day of tumor challenge after the rejec tion of the tumor heterograft or at a time when the size reached by the tumor was such as to suggest impending death of the animal. Immune sera used as controls were obtained from adult Lewis rats immunized either by two CBA mouse skin heterografts (separated by an interval of 15 days) or by two intrapenitoneal inoculations of 50 X 106 spleen cells each (same interval,same donor). Bloodserum wascollected onthe 15th day after secondary immunization. The serologic meth ods used were similar to those described by Palm (22, 23) . (irrespectiveof the strain) effectively removedhemag glutinating activity, whereas absorption with AVN rat, ham ster, or rabbit red cells was ineffective. This confirms the previ ous findings that antibodies present in heterologous sera are species specific but not strain specific (9, 25) .
(b) Cytotoxicity Tests: Equal volumes of rat serum (prey
at each of several dilutions and of mouse lymph node cell suspension (1.5 X 106 CBA cells in one ml of Krebs-Ringer phosphate solution) were mixed and maintained at 37Â°C for 30 minutes. An additional volume of fresh rabbit serum (absorbed at 4Â°C with packed, washed mouse and rat erythrocytes) was added as a source of com@le ment (C'), and the tubes were incubated for one hour at 37 C. 
Nicole Suciu-Foca Investigation of Mouse Cell Chimerism in Tolerant Rats. Chromosome patterns in the thymus, lymph nodes, spleen, and bone marrow of the rats were investigated on the day of tumor challenge and, in some animals with actively developing tumors, on the day of sacrifice before imminent death.
Investigation of the tumor developing in rats was carried out by histologic examination of sections stained with hematoxy lin and eosin, and inoculation of i0'@ cells from the developing tumors (a) to normal adult Lewis rats, and (b) back to mice of the strain from which the tumor had originated (B10 and CBA respectively).
Isologous passages of the tumors were carried out in the control groups that were used for comparisons of the periods of latency of the tumor and of the survival times of the animals.
In order to test whether heterografting of the MC1 /BL tumor resulted in loss of isoantigenic specificity, i0@ tumor cells were transferred from the rats to the congenic @ o D2 and B10 LP strains.
RESULTS

Induction of Tolerance to Ac/CBA Tumor Heterogralts in Rats by Heterogeneic Spleen Cells
Incidence of Tolerance.
In this experiment the optimal dose and period of administration of the antigen were estimated by determining the incidence rate of tolerance in rats challenged with Ac/CBA tumors 20 days after the last injection of CBA mouse spleen cells. In an attempt to investigate the ki netics of tolerance induced by various doses of antigen, the rate at which immunologic responsiveness returns was deter mined by challenging the animals at various intervals after the conclusion of paralyzing treatment. Three groups of rats were inoculated during the first 10 days of life with 200, 250, and 350 X 106 CBA mouse spleen cells respectively. Seven or 14 days after the end of the treatment the animals were chal lenged by CBA mouse skin grafts or Ac/CBA tumor grafts (30 x 106 tumor cells inoculated intramuscularly).
As shown in Table 2 , tumor grafts carried out on the 7th day resulted in the development of actively growing tumors in a high propor tion of rats in each group, whereas grafts administered on the 14th day underwent involution in most animals. Similarly, skin grafts placed on the 7th day after the end of treatment survived for as long as 28 days, whereas the survival time of
Incidence rate of tolerance to heterografts of Ac/CBA tumor in rats challenged 20 days after treatment with CBA spleen cells.
a Reciprocal of titer. Lewis rats treated during the first 10 days of life with 200 to 450 X 106 CBA mouse spleen cells were inoculated with 1050 to 1300 X 106 spleen cells (so as to attain a total dose of 1500
x 106 cells in all groups), administered in daily injections between the 40th and the 50th days of life. A control group including 5 rats not treated during the neonatal period was inoculated with 1500 X 106 spleen cells between the 40th and the 50th days of life. At the age of 60 days all the animals were challenged with 30 X 106 Ac/CBA cells administered intramuscularly.
The results shown in Table 3 demonstrate that, even though the total dose of spleen cells was the same in all groups, the incidence rate and degree of tolerance were still proportional to the dose administered during the neonatal pe nod.
Actively growing tumors invaded all of the thigh muscles and the inguinal and pelvic regions (Figs. 1â€"3 either on the day paralyzing treatment was resumed or on the day of challenge with the tumor. Twenty days later antibodies were still absent in the blood sera of animals with actively developing tumors while present in the blood sera of animals that had rejected the tumors. No mouse metaphases could be detected in the lymphoid tissues of rats that were sacrificed on the day of challenge with the tumor, nor could the clinical or histologic symptoms of a graft versus host reaction be demon strated in these groups.
Reinduction of Tolerance in Sensitized Animals
In order to test whether paralysis may be induced after the appearance of sensitized cells, an attempt was made to rein duce tolerance in rats that had been immunized by a skin heterograft during the period of recovery from paralysis. The experiments were designed to show whether tolerance was spe cific for the isoantigens of the donor species. For this purpose, 6 groups of rats were inoculated between the first and the 15th days of life with about 750 X 106 CBA mouse spleen cells administered in 15 injections (the first 5 on consecutive days, the subsequent ones on alternating days). At the age of 40 days, the rats of Groups 1, 2, and 3 received a skin graft from CBA donors. The grafts were rejected within 17 to 20 days. At 60 days of age, the rats of Group 1 were given one intramuscular injection of 100 X 106 MC1 /CBA sarcoma cells. The rats of Group 2 were given 100 X 106 MC1 /CBA sarcoma cells, and the rats of Group 3 were given 100 X 106 MC1/BL FEBRUARY 1969 Table 4 , actively growing tumors developed in all the groups 70th days of life. Out of the three groups that had had no skin that had been given 5 injections of tumor cells between the grafts, Group 4 was challenged by the intramuscular injection 60th and 70th days of life, irrespective of presensitization by of 100 X 106 MC1 /CBA tumor cells when the animals were 60 skin heterografts (Group 2) or of the origin of the tumor from days old, and Group 5 was given the same amount of cells in 5 the B10 strain (Group 3), which is genetically incompatible alternating intramuscular and intraperitoneal injections adminwith the donors of the tolerance-inducing stimulus (CBA istered from the 60th to the 70th days of life. Group 6 was mice). On the other hand, the same amount of tumor cells used as a control for the degree of tolerance on the 60th day, (100 X 106) administered in a single injection caused the de being inoculated with only 20 X 106 MC1 /CBA tumor cells (a velopment of actively growing tumors only in animals that had dose which determined the appearance of a relatively equal received a previous skin graft, but not in those that had been proportion of involuting and evoluting tumors when 40-dayso presensitized.
Actively growing tumors invaded all the via old tolerant rats were challenged) . Five 60-day-old rats used as cera in the peritoneal cavity with metastasis to the lung andTable CBA and B10 mice respectively confirmed their similarity to the original mouse tumors. The MC1/BL rat tumor maintained its strain specificity and could not be transplanted to B10 LP or B10 D2 mice. Mouse tumors grafted on the rats could not be maintained by subse quent serial passages in Lewis rats. Since these tumors display strict strain specificity, it must be assumed that cross-tolerance between isoantigens in the heterologous system cannot be ac counted for by antigenic loss or by overlapping of antigens (30) .
Induction of Tolerance to Ac/CBA Mouse Tumor by Treatment with Liver Cells.
In order to test whether the tolerance-inducing ability of heterologous cells actually depends on their morphologic and functional integrity, attempts were made to induce tolerance to Ac/CBA tumor heterografts by means of liver-cell suspen sions, in which about 80 percent of the cells were dead. One group of rats was treated with 147 X 106 liver cells adminis tered in 7 daily injections during the first week of life. From the 10th day to the 30th day of life, the animals were given 6 intrapenitoneal injections of 15 X 106 tumor cells each, at 5-day intervals (Table 5 ). Eight out of 20 animals treated in this manner developed actively growing tumors and died 20 to 25 days after the last inoculation (Fig. 4) . The other 12 ani mals displayed tumors that were rejected after 10 to 12 days of development. Histopathologic investigation of the tumor under way of rejection revealed the presence of extensive areas of necrosis and histiogranulocytic infiltration bordering on areas in which the tumor maintained its characteristic histolog ic structure and in which frequent cell divisions could be de tected. A second group (control) was not treated with liver cells during the neonatal period, but between the 16th and 30th days of life the animals were inoculated with tumor cells in conditions similar to those of the first group. Tumors did not develop in any of the animals. This confirms the tolerance inducing effect of liver-cell treatment administered to the ex perimental group.
Induction of Tolerance to Ac/CBA Mouse Tumors in Rats by Treatment with Tumor Cell Suspensions
We have attempted to ascertain whether the tolerance inducing effect of proliferative cells (as tumor cells are) is also conditioned by repeated inoculations of antigen. To this end, groups of 10 rats each were injected with Ac/CBA tumor cells on the first day of life (Group 1), daily during the first three days (Group 2) or five days (Group 3) of life. Group 4 was given daily injections of a mixture of spleen and tumor cells during the first 5 days of life. All animals were reinoculated with tumor cells (on the intramuscular route) on the 10th, 15th, 20th, and 25th days of life.
The results presented in Table 6 demonstrate that: (a) the essential factor determining the proportion of animals in which heterospecific tolerance was induced by the administra tion of tumor cells appears to be the duration of exposure to antigen of the newborn host rather than the total dose of 
DISCUSSION
The aim of this work was to document the kinetics of heter ospecific tolerance induction with respect to the dose of anti gen and to the duration of its administration. With a view to obtaining additional information on the mode of action of the tolerance-inducing stimulus, cells with or without the ability to multiply, i.e., spleen, liver, and tumor cells, were used for the induction of tolerance.
The chief finding of this study is that rats can be made tolerant to mouse tumors only by multiple injections of heter ologous cells (irrespective of their histologic origin) adminis tered from the first day of life, whereas single injections of antigen in the same dosage range given on the day of birth have no effect. From the results obtained by challenging the animals at a constant interval after the conclusion of the paral ysis treatment, it can be inferred that the degree of tolerance induced by multiple injections of spleen cells is antigen-dose dependent.
In case the total amount of antigen per immuno logically competent cell population plays the essential part in Inducti'n of tolerance to Ac/CBA tumor heterografts in rats by treatment with CBA liver cells. the process of tolerance induction, as it was postulated (11), one might assume that complete or partial tolerance is related to larger or smaller dose of antigen and is the consequence of the inhibition of the entire population of immunocompetent cells or of only some part of it (21) . Such correlation does not, however, appear to be absolute, since the degree of tolerance depends not only on the antigen dose, but also on the duration of the injection course and the interval between paralysis and challenge. It has, indeed, been observed that the later tolerance was tested, and the smaller and neonatally administered anti gen dose, the higher was the proportion of tumors rejected. These observations suggest that partial tolerance expresses the onset of recovery from paralysis and that the duration of toler ance is antigen-dose dependent (as has also been inferred from other researchers) (19) . Starting from Nossal's postulate (18) stating that a given antigen injection may both prime and para lyze, one may rather assume that the dynamics of the degrees of unresponsiveness is determined by the kinetics of the rela tions between the number of blocked cells and the number of sensitized cells (28â€"31). Recovery from paralysis could thus be conceived as a process developing gradually after interrup tion of the exogenous supply of antigen, as the number of sensitized cells exceeds that of blocked cells. This hypothesis is supported by our observation that, by administering antigen, breakdown of tolerance can be prevented with as great an efficiency as when the neonatally administered dose of antigen was higher. In other words, the degree of residual tolerance was higher at the moment when antigen was readministered (8) . It would thus appear that in the population of immuno competent cells, tolerance and immunity may coexist as antag onistic potentialities which may even, up to a certain time, be mutually interconverted depending on the available antigen concentration (28â€"31). This hypothesisâ€"implying the premise that to supress the process of recovery from paralysis, the antigen must block not only the previously tolerant cells (de pleted of an internal store of antigen) (5, 8, 16) or the virgin immunocytes (5, 16, 17) , but also the sensitized ones (6, 20) â€"is not in agreement with some views (21) according to which, in the case of partial tolerance, the contact between large doses of antigen and the sensitized cells would make them proliferate and cause the abolition of tolerance. Oui finding that tolerance may be reinduced by repeated injections of tumor cells, even in the case of rats which had rejected a skin heterograft following which humoral antibodies appeared, favors the hypothesis that the presence of sensitized cells is not incompatible with tolerance induction. The question now arises concerning why repeated antigen administrations are necessary for inducing heterospecific toler ance. Two aspects are to be examined in this connection:
(a) The tolerance-inducing effect of heterologous cells seems to be dependent on the multiple injections, irrespective of whether the cells are viable or have proliferative potentialities.
(b) The heterologous cells represent a mosaic ofantigens or of individual antigenic determinants, which may, theoretically, exercise either a cummulative effect (7), resulting from the totalling of the responses of each activated clone, or a competitive effect, in which the maximum immunologic response induced by the â€oeobligatory,â€•strong antigens imposes a limit to the host's abil ity to recognize the â€oefacultativeâ€• weak antigen (12) . The inter vention of the latter mechanism, which might rely on the gen etically predetermined differences between the size of some clones and the frequency of their appearances (10, 12) , could possibly explain the nonspecificity of tolerance with regard to the isoantigens of the heterologous donors (28, 30) . It must, therefore, be assumed that the appearance of clones compe tent to react against the various components of the heterolo gous complex does not occur synchronously, but depends on the ease (10) with which the antigens resulting from the decay of heterologous cells are being recognized by the stem cells.
If at the level of virgin immunocyte, the probability of being primed or blocked is antigen-dose dependent (5, 6, 15, 17, 20) , then induction of tolerance in the greater part of the immunologically competent cell population will be condi tioned by the availability of a high amount of antigen at the time the recognition process is taking place (17) . If during the course of this process the cells encountering low antigen con centrations are derepressed and stimulated to proliferate (5, 6, 20, 26) , we have to infer that to prevent substitution of the blocked cell population by proliferative immune cells, the anti gen must block the cytodifferentiation process of the activated immunocytes.
According to various hypotheses (6, 20) , such a process might be the consequence of a lethal or paralyzing effect of large amounts of antigen on the sensitized cells or of the haustive sensitization of plasmocytes (15, 20 
